Oncology Update

Oncology Update

Michael Smart

ONF 2009, 36(2), 239-241. DOI: 10.1188/09.ONF.239-241

Jump to a section


    Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., et al. (2008). K-ras mutations and benefit from cetuximab in advanced colorectal cancer. New England Journal of Medicine, 359(17), 1757-1765.
    Weber, J., & McCormack, P. L. (2008). Panitumumab: Metastatic colorectal cancer with wild-type KRAS. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals, and Gene Therapy, 22(6), 403-411.
    Devine, S., Vij, R., Rettig, M., Todt, L., McGlauchlen, K., Fisher, N., et al. (2008). Rapid mobiliztion of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Blood, 112(4), 990-998.
    Nalluri, S. R., Chu, D., Keresztes, R., Zhu, X., & Wu, S. (2008). Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients. JAMA, 300(19), 2277-2285.
    Zhang, S. M., Cook, N. R., Albert, C. M., Gaziano, J. M., Buring, J. E., & Manson, J. E. (2008). Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: A randomized trial. JAMA, 300(17), 2012-2021.
    Chlebowski, R. T., Johnson, K. C., Kooperberg, C., Pettinger, M., Wactawski-Wende, J., Rohan, T., et al. (2008). Calcium plus vitamin D supplementation and the risk of breast cancer. Journal of the National Cancer Institute, 100(22), 1581-1591.
    Hamilton, R. J., Goldberg, K. C., Platz, E. A., & Freedland, S. J. (2008). The influence of statin medications on prostate-specific antigen levels. Journal of the National Cancer Institute, 100(21), 1511-1518.
    Armenian, S. H., Sun, C., Francisco, L., Steinberger, J., Kurian, S., Wong, F. L., et al. (2008). Late congestive heart failure after hematopoietic stem cell transplantation. Journal of Clinical Oncology, 26(34), 5537-5543.